Vimarsana
Biggest News Aggregation in the World

Improves Survival News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Improves Survival. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Improves Survival Today - Breaking & Trending Today

Redefining Cancer Care for Children With Blinatumomab - Vimarsana News

Redefining Cancer Care for Children With Blinatumomab

A groundbreaking cancer drug, Blina, brings relief to children like Arthur, offering effective treatment with minimal side effects.

AstraZeneca advances scientific leadership in hematology at ASH 2023 - Vimarsana News

AstraZeneca advances scientific leadership in hematology at ASH 2023

CALQUENCE six-year follow-up data reinforce long-term benefit in chronic lymphocytic leukemia, and data across multiple hematology assets showcase breadth of promising early pipeline New,...

Tanner Pharma Group: Tanner Pharma Increases Europe-Based Inventory of Leukine to Expand Availability and Enhance Response to Potential Radiation Exposure Due to the Ongoing Conflict in Ukraine - Vimarsana News

Tanner Pharma Group: Tanner Pharma Increases Europe-Based Inventory of Leukine to Expand Availability and Enhance Response to Potential Radiation Exposure Due to the Ongoing Conflict in Ukraine

Leukine is FDA Approved to Treat Acute Radiation Syndrome (ARS) and Recommended in EMEA/CPMP Guidance to Treat Systemic Sulfur Mustard (HD) Gas Exposure Tanner Pharma Group, an international distributor

Tanner Pharma increases Europe-based inventory of Leukine® to expand availability and enhance response to potential radiation exposure due to the ongoing conflict in Ukraine - Vimarsana News

Tanner Pharma increases Europe-based inventory of Leukine® to expand availability and enhance response to potential radiation exposure due to the ongoing conflict in Ukraine

Tanner Pharma Group, an international distributor of essential medicines, announced that it has significantly increased its inventory of Leukine ...

Partner Therapeutics Announces Publication of Two Studies Demonstrating Leukine® Improves Survival in Acute Radiation Syndrome (ARS) - Vimarsana News

Partner Therapeutics Announces Publication of Two Studies Demonstrating Leukine® Improves Survival in Acute Radiation Syndrome (ARS)

Partner Therapeutics Announces Publication of Two Studies Demonstrating Leukine® Improves Survival in Acute Radiation Syndrome (ARS) - Studies Showed Statistically Significant Improvements in Survival in Subjects Treated with Leukine Starting 48 Hours After Acute, High Dose Radiation Exposure without Need for Blood Transfusions or Other Forms of Intensive Supportive Care - Leukine Administration Starting 48, 72, 96 and 120 Hours after Lethal Radiation Exposure: - Enhanced Recovery of Platelets, Lymphocytes, Neutrophils and Reticulocytes - Reduced Frequency, Severity and Duration of Infection...